Logo Image
Publication|Articles|July 30, 2026

Dermatology Times

  • Dermatology Times, July 2026 (Vol. 47. No. 07)
  • Volume 47
  • Issue 07

RAD 2026: Experts Weigh In on AD Pipeline, Pediatric Care, and Personalized Treatment

Fact checked by: Georgina Carson

RAD 2026 experts unpacked new IL-13, JAK, STAT6 and OX40 options, CHE and pediatric gaps, plus overlooked comorbidities shaping AD care.

The 2026 Revolutionizing Atopic Dermatitis (RAD) Conference, held from June 17 to 19 in Nashville, Tennessee, brought together dermatology clinicians to address the full scope of atopic dermatitis (AD) management, from emerging pipeline therapies and chronic hand eczema (CHE) to pediatric care gaps and the comorbidity burden that often goes underrecognized in clinical practice. Dermatology Times spoke with presenters on-site to capture their insights on where the field is headed.